Contemporary prevalence and predictors of anxiety among patients living with HIVAIDS in Ghana

Objectives: To identify the prevalence and associated factors of anxiety in people living with HIV/AIDS in a tertiary centre in Ghana. Design: The study employed a cross-sectional design. Setting: The study was conducted in the outpatient HIV clinic of a tertiary hospital. Participants: Participants were adult PLWHA receiving OPD care, including those established on combined antiretroviral therapy (cART) and newer patients who were not on cART. Four hundred ninety-five participants aged ≥30 years were consecutively enrolled on the study. Interventions: Demographic and clinical data were collected using standard questionnaires and patient files. Anxiety was assessed using the Hospital Anxiety and Depression Scale (HADS). Multivariate logistic regression analysis was done to identify associated factors. Main outcome measure: Proportion of PLWHA who had HADS score of ≥8 Results: Overall prevalence of anxiety was 61.0% (95%CI: 56.6 ­ 65.3), with no significant difference between recently diagnosed (≤ 6 months, 64.3%) and those with established diagnoses (>6 months, 59.1%). Urban residence (aOR: 1.67, 95%CI: 1.12 ­ 2.51), alcohol use (aOR: 1.64, 95%CI: 1.13 ­ 2.38) and depression (aOR: 13.62, 95%CI: 7.91 ­ 23.45) were independently associated with anxiety. Conclusion: In this sample, 6 in 10 Ghanaian PLWHA had evidence of anxiety. Liaison with the national mental health service for more comprehensive and integrated care and further research into the mental health of PLWHA is recommended to reduce this high burden of anxiety

Combination of HIV-1 and Diabetes Enhances Blood Brain Barrier Injury via Effects on Brain Endothelium and Pericytes.

Despite combined antiretroviral therapy (ART) achieving efficient HIV replication control, HIV-associated neurocognitive disorders (HAND) continue to be highly prevalent in HIV-infected patients. Diabetes mellitus (DM) is a well-known comorbidity of HAND in HIV-infected patients. Blood brain barrier (BBB) dysfunction has been linked recently to dementia development, specifically in DM patients. BBB injury exists both in HIV and DM, likely contributing to cognitive decline. However, its extent, exact cellular targets and mechanisms are largely unknown. In this report, we found a decrease in pericyte coverage and expression of tight junction proteins in human brain tissues from HIV patients with DM and evidence of HAND when compared to HIV-infected patients without DM or seronegative DM patients. Using our in vitro BBB models, we demonstrated diminution of barrier integrity, enhanced monocyte adhesion, changes in cytoskeleton and overexpression of adhesion molecules in primary human brain endothelial cells or human brain pericytes after exposure to HIV and DM-relevant stimuli. Our study demonstrates for the first-time evidence of impaired BBB function in HIV-DM patients and shows potential mechanisms leading to it in brain endothelium and pericytes that may result in poorer cognitive performance compared to individuals without HIV and DM.

HIV infection and stroke.

The landscape of human immunodeficiency virus (HIV) infection is changing with the increasing coverage of antiretroviral therapy (ART). Patients are living longer but continually exposed to a virologically suppressed HIV infection. This has resulted in a decrease in acquired immune deficiency syndrome (AIDS)-related complications such as opportunistic infections, and an increase in non-AIDS complications such as stroke. In this era, stroke is perhaps the most important neurologic complication of HIV infection. Furthermore, stroke is more of a heterogeneous disease in people living with HIV infection and therefore needs to be approached systematically. Many of the etiologies are treatable. HIV-associated vasculopathy is perhaps the most common etiology in this population and our understanding of this is still evolving. Moreover, the treatment of HIV infection may contribute to an excess risk of stroke and interact with stroke therapies.

De Novo intracerebral aneurysm in a child with acquired immunodeficiency syndrome.

Human immunodeficiency virus (HIV) infection associated aneurysmal vasculopathy is a rare complication of HIV infection affecting the pediatric and adult population. We present a case of a 7-year-old male child known to have a congenitally acquired HIV infection presenting with a ruptured left distal internal carotid artery fusiform aneurysm that was diagnosed on MRI scans 6 months prior to his presentation. He underwent craniotomy and successful aneurysm reconstruction. He had uncomplicated postoperative course and experienced a good recovery. This case is among the few reported pediatric cases of HIV-associated cerebral arteriopathy to undergo surgery. We also reviewed the relevant literature of this rare condition.

¹8F-FDG PET/CT in HIV-related central nervous system pathology.

PURPOSE: To evaluate the utility of ¹8F-FDG PET/CT in suspected cerebral pathology in HIV-infected individuals. METHODS: ¹8F-FDG PET/CT scans from 29 HIV-infected individuals (29 brain scans, 22 whole-body scans) who presented with neurological symptoms and signs were retrospectively reviewed and compared with subsequent clinical investigations. RESULTS: The majority of patients (n=25) were referred to differentiate infection from malignant causes of cerebral pathology. Ten of the 11 patients with an eventual diagnosis of toxoplasmosis infection were correctly diagnosed by ¹8F-FDG PET/CT showing lesional uptake less than that of normal brain cortex (mean SUVmax 3.5, range 1.9 - 5.8). All five patients with a final diagnosis of primary central nervous system lymphoma (PCNSL) were correctly diagnosed by ¹8F-FDG PET/CT showing lesional uptake greater than that of normal brain cortex (mean SUVmax 18.8, range 12.4 - 29.9). Four of the five patients with ¹8F-FDG PET/CT features suggesting a vasculitic process had vasculitis confirmed as the final diagnosis. Three patients showed variable uptake in multiple cerebral lesions (including final diagnoses of tuberculosis and metastases from lung cancer in two patients) and there were four other miscellaneous diagnoses. In 12 patients biopsies were performed at sites guided by PET abnormality (7 brain, 5 lymph nodes) confirming or excluding significant disease in 11. CONCLUSION: ¹8F-FDG PET/CT is particularly useful for differentiating between infection and PCNSL in HIV-infected patients with a cerebral lesion on MRI or CT. ¹8F-FDG PET/CT was also a helpful tool in the diagnostic work-up of patients with other HIV-related cerebral pathology. Additional advantages of ¹8F-FDG PET/CT are the abilities to assess abnormally increased glucose metabolism in the body and to identify potential sites for biopsy.

The roles of neutral sphingomyelinases in neurological pathologies.

The neutral sphingomyelinases (N-SMases) are a group of Mg²âº-dependent enzymes with a pH optimum in the neutral range. N-SMases catalyze the conversion of sphingomyelin to ceramide and have been found particularly enriched in brain tissue. N-SMase activity has been implicated in many physiological and pathological processes affecting the brain and nervous system. In this review, we discuss the proposed functions of N-SMase with a particular emphasis on its role in neurological disorders, such as age-related neurodegeneration, Alzheimer's disease, HIV-associated dementia, atherosclerosis, ischemia-reperfusion injury, and cancer.

[Therapeutic advances in pharmaceutical treatment of neuropathic pain]. / Avancées dans le traitement pharmacologique des douleurs neuropathiques.

Neuropathic pain is difficult to treat. Recommended first-line treatments include tricyclic antidepressants and alpha2delta agonists pregabalin and gabapentin for multiple neuropathic conditions, the antidepressants duloxetine and venlafaxine in diabetic painful neuropathies and lidocaine patches for postherapetic neuralgia. Therapeutic prospects include focal therapy with sustained analgesic efficacy (capsaicin patches, botulinum toxin), treatments acting on new targets (i.e., cytokine inhibitors, metabotropic glutamate inhibitors, TRPV1 antagonists). The methodology of clinical trials also tends to take better into account the symptomatic profiles of patients, which should contribute to better prediction or responders to treatment.

HIV/AIDS patients with HIV vasculopathy and VZV vasculitis: a case series.

PURPOSE: Stroke is a rising cause of mortality in human immunodeficiency virus (HIV) and acquired immunodeficiency syndrome (AIDS) populations. The etiology of stroke remains at the core of the decision-making process to treat and prevent recurrent events. In this population HIV vasculopathy (HIV-V) and varicella zoster virus (VZV) vasculitis are elusive causes of stroke. This study investigated radiological markers that could help identify possible etiological causes. METHODS: A series of nine consecutive patients seen at a large metropolitan hospital who presented with AIDS and stroke with the suspicion of either HIV vasculopathy (HIV-V) or VZV vasculitis (VZV-V) were included. A standardized diagnostic approach was used to for HIV-V and VZV-V. Data on frequencies and typical images are reported. RESULTS: Of the nine patients five had VZV-V and four had HIV-V. Patients with VZV-V were generally younger than those with HIV-V; however, no other significant demographic or cardiovascular differences were found. Of the five patients with VZV-V four had small, deep, subcortical ischemic strokes and only one in this group had a large, cortical, hemispheric stroke but in the HIV-V group three patients had large, cortical hemispheric strokes and only one patient had small, subcortical ischemic strokes. CONCLUSIONS: In this series VZV-V seemed to present more often with deep-seated ischemic infarcts, while HIV-V appeared to be associated with large, hemispheric stroke. It seems plausible that this difference is related to the type of arteries infected by each virus. These findings are preliminary and should be confirmed with better studies.

HIV-associated neurocognitive disorders

HIV infection is associated with disturbances in brain function referred to as HIV-associated neurocognitive disorders (HAND). This literature review outlines the recently revised diagnostic criteria for the range of HAND from the earliest to the more advanced stages: (i) asymptomatic neurocognitive impairment; (ii) mild neurocognitive disorder; and (iii) HIVassociated dementia. Relevant literature is also reviewed regarding the differential impact upon component cognitive domains known to be affected in HAND; which in turn should ideally be targeted during clinical and neuropsychological assessments: psychomotor and information processing speed; learning and memory; attention and working memory; speech and language; executive functioning and visuospatial functioning. A discussion outlining the neuropsychological tools used in the diagnostic screening of HAND is also included. The central mechanisms of HAND appear to revolve primarily around psychomotor slowing and cognitive control over mental operations; possibly reflecting the influence of disrupted fronto-striatal circuits on distributed neural networks critical to cognitive functions. The accurate assessment and diagnosis of HAND depends on meeting the need for statistically sound neuropsychological assessment techniques that may be used confidently in assessing South African populations; as well as the development of relevant norms for comparison of test performance data

Hallazgos neuropatológicos de la infección por VIH-SIDA: estudio de autopsias en el Hospital Universitario de Santander, Bucaramanga, Colombia / Neuropathologic features of the infection HIV-AIDS: study autopsy in the Hospital Universitario de Santander, Bucaramanga, Colombia

Objetivo: Describir las alteraciones macro y microscópicas observadas en el sistema nervioso central (SNC) de pacientes que fallecieron por la infección con VIH-SIDA. Metodología: Estudio retrospectivo de autopsias del 1 de enero de 2004 al 31 de diciembre de 2007 en un hospital público de tercer nivel en la ciudad de Bucaramanga, Santander. Resultados: El hallazgo neuropatológico más común en pacientes que fallecieron por la infección VIH-SIDA fue toxoplasmosis cerebral, 17 casos (28.3%) luego criptococosis cerebral, 7 casos (11.6%), tuberculosis del SNC, 3 casos (5%), encefalopatía por HIV, 2 casos (3.3%), meningitis piógena, un caso (1.6%) y hallazgos inespecíficos,2 casos (3.3%).  No hubo lesiones neoplásicas, infecciones por citomegalovirus, herpes, histoplasmosis ni leucoencefalopatía multifocal progresiva (LMP) en ninguno de los casos. En el presente estudio se encontraron cambios en el SNC en 32 casos (53.1%), que, después del respiratorio (39-65%), fue el sistema más afectado por las complicaciones relacionadas con la enfermedad por VIH. La presencia de lesión directa (encefalitis por HIV) y al mismo tiempo infección oportunista se encontró sólo en un caso (1.6%). Conclusiones: En Bucaramanga las infecciones oportunistas fueron las complicaciones más frecuentes y graves a nivel del SNC en los enfermos con VIH-SIDA, de ellas la toxoplasmosis cerebral fue la que más comprometió el SNC de los pacientes con infección con VIH-SIDA, y se expresó morfológicamente como una meningoencefalitis necrosante, ubicada de manera preferencial en la región de los ganglios basales.

Objective: To describe the macroscopic and microscopic alterations observed in the central nervous system (CNS) in patients who died through HIV-AIDS infection. Method used: Retrospective study of autopsies from January 1st 2004 to December 31st 2007 in a third-level public hospital at Bucaramanga, Santander.Results: The most common neuro-pathological findings in patients who died through HIV-AIDS infection were cerebral toxoplasmosis, 17 cases (28.3%); followed by cerebral cryptococcosis, 7 cases (11.6%); CNS tuberculosis, 3 cases (5%); HIV encephalitis, 2 cases (3.3%); and bacterial meningitis, 1 case (1.6%). Neoplasm lesions, CMV infection, herpes infection, histoplasmosis, and progressive multifocal leucoencephalopathy (PML) were not found in any case. In this study, changes were seen in the CNS in 32 cases (53.1%), which after the respiratory system (39-65%) was the most affected system for complications related to HIV infection. HIV-induced encephalopathy simultaneously with an opportunistic infection was only found in 1 case (1.6 %). Conclusion: In Bucaramanga, opportunistic infections are the most frequent and serious complications in the CNS of individuals with HIV-AIDS; among them cerebral toxoplasmosis was the most frequently observed complication in the CNS of patients with HIV-AIDS, appearing morphologically as a meningoencephalitis with necrosis and large lesions localized in the gangliobasal region.